Evidence map›Paper›PMID 30918278›Full record

ArticleScientific reports2019

Modulation of the p75 neurotrophin receptor suppresses age-related basal forebrain cholinergic neuron degeneration.

Youmei Xie, Rick B Meeker, Stephen M Massa, Frank M Longo

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 36 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. In vivo functions of p75Trends in pharmacological sciences · 2021
    Review
  10. Ablation of p75Translational psychiatry · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. p75NTR and DR6 Regulate Distinct Phases of Axon Degeneration Demarcated by Spheroid Rupture.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Youmei XieDepartment of Neurology, University of North Carolina, Chapel Hill, NC, 27599, USA.
Rick B MeekerDepartment of Neurology, University of North Carolina, Chapel Hill, NC, 27599, USA.
Stephen M MassaDepartment of Neurology, San Francisco Veterans Administration Health Care System and University of California San Francisco, San Francisco, CA, 94121, USA.
Frank M LongoDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, 94305, USA. flongo@stanford.edu.
University of North Carolina at Chapel Hill · USStanford University · USUniversity of California, San Francisco · US

Funding

Neurotrophin Protection in HIV and AgingR01NS083164 · NINDS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MEEKER, RICK B · 2013 to 2016
$1.1M
Trk Ligands for Treatment of Traumatic Brain InjuryI01BX000267 · VA · VETERANS AFFAIRS MED CTR SAN FRANCISCO · PI MASSA, STEPHEN M. · 2009 to 2018
–
BLRD VA I01 BX000267NINDS NIH HHS R01 NS083164
6 · The paper itself

Abstract

Age-related degeneration of basal forebrain cholinergic neurons (BFCNs) is linked to cognitive impairment. The p75 neurotrophin receptor (p75

Indexed as

AnimalsBasal ForebrainBlotting, WesternCholinergic NeuronsFluorescent Antibody TechniqueHippocampusImmunohistochemistryIsoleucineMiceMorpholinesNerve DegenerationNeuritesParietal LobeReceptor, Nerve Growth FactorIsoleucineLM11A-31MorpholinesReceptor, Nerve Growth Factor

Identifiers

PMID30918278
PMCPMC6437186
OpenAlexW2924615230

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.